Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer

Abstract Regarding TNM staging in breast cancer, T2 category is currently not divided into subcategories even though it covers a wider range of tumor sizes than T1 category. Using Korean Breast Cancer Registry database, data of 41 071 women diagnosed as non‐metastatic T2 breast cancer between 2001 a...

Full description

Bibliographic Details
Main Authors: Jiwoong Jung, Young Jin Suh, Byung Kyun Ko, Eun Sook Lee, Eun‐Kyu Kim, Nam Sun Paik, Kyung Do Byun, Ki‐Tae Hwang
Format: Article
Language:English
Published: Wiley 2018-11-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.1831
_version_ 1797681449991667712
author Jiwoong Jung
Young Jin Suh
Byung Kyun Ko
Eun Sook Lee
Eun‐Kyu Kim
Nam Sun Paik
Kyung Do Byun
Ki‐Tae Hwang
author_facet Jiwoong Jung
Young Jin Suh
Byung Kyun Ko
Eun Sook Lee
Eun‐Kyu Kim
Nam Sun Paik
Kyung Do Byun
Ki‐Tae Hwang
author_sort Jiwoong Jung
collection DOAJ
description Abstract Regarding TNM staging in breast cancer, T2 category is currently not divided into subcategories even though it covers a wider range of tumor sizes than T1 category. Using Korean Breast Cancer Registry database, data of 41 071 women diagnosed as non‐metastatic T2 breast cancer between 2001 and 2014 were analyzed. Cutoff value for optimal tumor size was approximated by receiver operating characteristic (ROC) curve to subcategorize T2 tumors. Overall survival (OS) was compared between two subcategories. Median follow‐up period was 65 months. Of 41 071 patients, 4504 (11.0%) died. Based on ROC curve analysis, 3.0 cm was selected as the cutoff value. Five‐year OS rate was 91% in patients with breast tumors ≤3.0 cm (T2a) and 86% in patients with breast tumors >3.0 cm (T2b) (log‐rank P < 0.001). T2b subcategory showed worse OS than T2a subcategory regardless of node status (log‐rank P < 0.001 for all node categories). Within every subgroup defined by primary OS analysis covariates, T2b subcategory consistently showed worse outcome compared to T2a subcategory. By multivariate analysis, T2b subcategory was a significant independent prognostic factor of OS (hazard ratio: 1.26, 95% CI = 1.18‐1.34). T2 category of breast cancer could be subcategorized into T2a and T2b with a cutoff value of 3 cm. These subcategories definitely showed different OSs even after adjusted for known prognostic factors. Subcategorization of T2 category might be useful for predicting prognosis more accurately and tailoring adjuvant therapy.
first_indexed 2024-03-11T23:45:00Z
format Article
id doaj.art-762d024397a84407b5cb6b93955c3d86
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-03-11T23:45:00Z
publishDate 2018-11-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-762d024397a84407b5cb6b93955c3d862023-09-19T11:30:57ZengWileyCancer Medicine2045-76342018-11-017115514552410.1002/cam4.1831Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancerJiwoong Jung0Young Jin Suh1Byung Kyun Ko2Eun Sook Lee3Eun‐Kyu Kim4Nam Sun Paik5Kyung Do Byun6Ki‐Tae Hwang7Department of Surgery Seoul Medical Center Seoul KoreaDepartment of Surgery St. Vincent's Hospital College of Medicine The Catholic University of Korea Suwon KoreaDepartment of Surgery Ulsan University Hospital University of Ulsan College of Medicine Ulsan KoreaCenter for Breast Cancer Research Institute and Hospital National Cancer Center Goyang KoreaDepartment of Surgery Seoul National University Bundang Hospital Seoul National University College of Medicine Seongnam KoreaDepartment of Surgery Ewha Womans University Mokdong Hospital Ewha Womans University College of Medicine Seoul KoreaDepartment of Surgery Dong‐A University Medical Center Dong‐A University College of Medicine Busan KoreaDepartment of Surgery Seoul National University Boramae Medical Center Seoul KoreaAbstract Regarding TNM staging in breast cancer, T2 category is currently not divided into subcategories even though it covers a wider range of tumor sizes than T1 category. Using Korean Breast Cancer Registry database, data of 41 071 women diagnosed as non‐metastatic T2 breast cancer between 2001 and 2014 were analyzed. Cutoff value for optimal tumor size was approximated by receiver operating characteristic (ROC) curve to subcategorize T2 tumors. Overall survival (OS) was compared between two subcategories. Median follow‐up period was 65 months. Of 41 071 patients, 4504 (11.0%) died. Based on ROC curve analysis, 3.0 cm was selected as the cutoff value. Five‐year OS rate was 91% in patients with breast tumors ≤3.0 cm (T2a) and 86% in patients with breast tumors >3.0 cm (T2b) (log‐rank P < 0.001). T2b subcategory showed worse OS than T2a subcategory regardless of node status (log‐rank P < 0.001 for all node categories). Within every subgroup defined by primary OS analysis covariates, T2b subcategory consistently showed worse outcome compared to T2a subcategory. By multivariate analysis, T2b subcategory was a significant independent prognostic factor of OS (hazard ratio: 1.26, 95% CI = 1.18‐1.34). T2 category of breast cancer could be subcategorized into T2a and T2b with a cutoff value of 3 cm. These subcategories definitely showed different OSs even after adjusted for known prognostic factors. Subcategorization of T2 category might be useful for predicting prognosis more accurately and tailoring adjuvant therapy.https://doi.org/10.1002/cam4.1831breast neoplasmsprognosisTNM stagingtumor staging
spellingShingle Jiwoong Jung
Young Jin Suh
Byung Kyun Ko
Eun Sook Lee
Eun‐Kyu Kim
Nam Sun Paik
Kyung Do Byun
Ki‐Tae Hwang
Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer
Cancer Medicine
breast neoplasms
prognosis
TNM staging
tumor staging
title Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer
title_full Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer
title_fullStr Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer
title_full_unstemmed Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer
title_short Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer
title_sort clinical implication of subcategorizing t2 category into t2a and t2b in tnm staging of breast cancer
topic breast neoplasms
prognosis
TNM staging
tumor staging
url https://doi.org/10.1002/cam4.1831
work_keys_str_mv AT jiwoongjung clinicalimplicationofsubcategorizingt2categoryintot2aandt2bintnmstagingofbreastcancer
AT youngjinsuh clinicalimplicationofsubcategorizingt2categoryintot2aandt2bintnmstagingofbreastcancer
AT byungkyunko clinicalimplicationofsubcategorizingt2categoryintot2aandt2bintnmstagingofbreastcancer
AT eunsooklee clinicalimplicationofsubcategorizingt2categoryintot2aandt2bintnmstagingofbreastcancer
AT eunkyukim clinicalimplicationofsubcategorizingt2categoryintot2aandt2bintnmstagingofbreastcancer
AT namsunpaik clinicalimplicationofsubcategorizingt2categoryintot2aandt2bintnmstagingofbreastcancer
AT kyungdobyun clinicalimplicationofsubcategorizingt2categoryintot2aandt2bintnmstagingofbreastcancer
AT kitaehwang clinicalimplicationofsubcategorizingt2categoryintot2aandt2bintnmstagingofbreastcancer